1. Home
  2. HVT vs SLN Comparison

HVT vs SLN Comparison

Compare HVT & SLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HVT
  • SLN
  • Stock Information
  • Founded
  • HVT 1885
  • SLN 1994
  • Country
  • HVT United States
  • SLN United Kingdom
  • Employees
  • HVT N/A
  • SLN N/A
  • Industry
  • HVT Other Specialty Stores
  • SLN Biotechnology: Pharmaceutical Preparations
  • Sector
  • HVT Consumer Discretionary
  • SLN Health Care
  • Exchange
  • HVT Nasdaq
  • SLN Nasdaq
  • Market Cap
  • HVT 364.9M
  • SLN 352.2M
  • IPO Year
  • HVT N/A
  • SLN N/A
  • Fundamental
  • Price
  • HVT $22.64
  • SLN $5.56
  • Analyst Decision
  • HVT Strong Buy
  • SLN Strong Buy
  • Analyst Count
  • HVT 1
  • SLN 4
  • Target Price
  • HVT $45.00
  • SLN $61.50
  • AVG Volume (30 Days)
  • HVT 116.1K
  • SLN 439.4K
  • Earning Date
  • HVT 02-19-2025
  • SLN 03-11-2025
  • Dividend Yield
  • HVT 5.56%
  • SLN N/A
  • EPS Growth
  • HVT N/A
  • SLN N/A
  • EPS
  • HVT 1.60
  • SLN N/A
  • Revenue
  • HVT $749,290,000.00
  • SLN $21,773,221.00
  • Revenue This Year
  • HVT N/A
  • SLN N/A
  • Revenue Next Year
  • HVT $6.06
  • SLN $104.98
  • P/E Ratio
  • HVT $14.15
  • SLN N/A
  • Revenue Growth
  • HVT N/A
  • SLN N/A
  • 52 Week Low
  • HVT $21.05
  • SLN $4.82
  • 52 Week High
  • HVT $37.05
  • SLN $27.72
  • Technical
  • Relative Strength Index (RSI)
  • HVT 54.25
  • SLN 33.35
  • Support Level
  • HVT $22.05
  • SLN $4.82
  • Resistance Level
  • HVT $22.62
  • SLN $7.87
  • Average True Range (ATR)
  • HVT 0.54
  • SLN 0.65
  • MACD
  • HVT 0.14
  • SLN 0.02
  • Stochastic Oscillator
  • HVT 91.09
  • SLN 22.70

About HVT Haverty Furniture Companies Inc.

Haverty Furniture Companies Inc is a specialty retailer of residential furniture and accessories. It provides various products such as Sofa Tables, Sleepers, End Tables, Cocktail Tables, Accent Pieces, Display Cabinets, Wall Decor, floral and Tress, and other related products. The company operates primarily in the Southern and Midwestern U.S. All its activities are encompassed in its Merchandise division. The company derives the majority of its revenue from its upholstery products and, secondarily, from bedroom furniture.

About SLN Silence Therapeutics Plc American Depository Share

Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid. its pipeline products are; SLN360 therapy designed to temporarily block a specific gene's message that would otherwise trigger an unwanted effect. By silencing the LPA gene, the levels of Lp(a) are lowered, which in turn is expected to lower the risks of heart diseases, heart attacks, and strokes, and SLN124 therapy aims to temporarily silence TMPRSS6, a gene that prevents the liver from producing a particular hormone that controls iron levels in the body hepcidin. As hepcidin increases, iron levels in the blood are expected to decrease, which may increase the production of healthy red blood cells, thereby reducing anemia.

Share on Social Networks: